Genetic approaches to studying mouse models of human seizure disorders

Advances in Experimental Medicine and Biology

Volumn 548, Issue , 2004, Pages 1-11

  Yang, Yan ^a   Frankel, Wayne N ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID; BETA CARBOLINE; BICUCULLINE; CONVULSANT AGENT; EXCITATORY AMINO ACID; GLUTAMIC ACID; KAINIC ACID; NICOTINE; PENTETRAZOLE;

AUDIOGENIC SEIZURE; AUDITORY STIMULATION; BEHAVIOR; BRAIN DEPTH STIMULATION; CONVULSION; ELECTRIC SHOCK; ELECTROENCEPHALOGRAPHY; ELECTROPHYSIOLOGY; ELECTROPORATION; EPILEPSY; GENE IDENTIFICATION; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENE TARGETING; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GENETIC RECOMBINATION; GENETIC SUSCEPTIBILITY; GENETICS; GENOME; HUMAN; MISSENSE MUTATION; MOLECULAR BIOLOGY; MOLECULAR GENETICS; MORPHOLOGICAL TRAIT; MOUSE STRAIN; NEUROLOGIC EXAMINATION; NONHUMAN; NULL ALLELE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SEIZURE; SEIZURE SUSCEPTIBILITY; SEIZURE THRESHOLD; SENSITIVITY ANALYSIS; STEM CELL; STIMULUS RESPONSE; SURVIVAL;

ANIMALIA;

EID: 3242756611     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4757-6376-8_1     Document Type: Review

References (51)

1. Anderson VE, Hauser WA, Rich SS. Genetic heterogeneity and epidemiology of the epilepsies. In: Delgado-Escueta AV, Wilson WA, Olsen RW, Porter RJ, eds. Jasper's Basic Mechanisms of the Epilepsies. Philadelphia: Lippincott Williams & Wilkins, 1999.
2. Meisler MH, Kearney J, Ottman R et al. Identification of epilepsy genes in human and mouse. Annu Rev Genet 2001; 35:567-88.
3. 2+ channel beta subunit gene Cchb4 is associated with ataxia and seizures in the lethargic (lh) mouse. Cell 1997; 88:385-392.
4. Escayg A, De Waard M, Lee DD et al. Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am J Hum Genet 2000; 66: 1531-1539.
5. Krall RL, Penry JK, Kupferberg HJ et al. Antiepileptic drug development: I. History and a program for progress. Epilepsia 1978; 4:393-408.
6. Frankel WN. Detecting genes in new and old mouse models for epilepsy: A prospectus through the magnifying glass. Epilepsy Res 1999; 36:97-110.
7. Gusella JF, MacDonald ME. Molecular genetics: Unmasking polyglutamine triggers in neurodegenerative disease. Nat Rev Neurosci 2000; 2:109-15.
8. Bronson SK, Smithies O. Altering mice by homologous recombination using embryonic stem cells. J Biol Chem 1994; 269:27155-8.
9. Capecchi MR. The new mouse genetics: Altering the genome by gene targeting. Trends Genet 1989; 5:70-6.
10. Lewandoski M. Conditional control of gene expression in the mouse. Nat Rev Genet 2001; 10:743-55.
11. Kask K, Zamanillo D, Rozov A et al. The AMPA receptor subunit GluR-B in its Q/R site-unedited form is not essential for brain development and function. Proc Natl Acad Sci USA 1998; 95:13777-82.
12. Cossette P, Liu L, Brisebois K et al. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nature Genet 2002; 31:184-189.
13. Kalachikov S, Evgrafov O, Ross B et al. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nature Genet 2002; 30:335-341.
14. Morante-Redolat JM, Gorostidi-Pagola A, Piquer-Sirerol A et al. Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy. Hum Mol Genet 2002; 11:1119-1128.
15. Baulac S, Huberfeld G, Gourfinkel-An I et al. First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene. Nat Genet 2001; 28:46-8.
16. Wallace RH, Marini C, Petrou S et al. Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet 2001; 28:49-52.
17. Sugawara T, Tsurubuchi Y, Agarwala KL et al. A missense mutation of the Na+ channel alpha II subunit gene Na(v)1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc Natl Acad Sci USA. 2001; 98:6384-9.
18. Escayg A, MacDonald BT, Meisler MH et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet 2000; 24:343-5.
19. Claes L, Del-Favero J, Ceulemans B et al. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 2001; 68:1327-32.
20. +-channel beta 1 subunit gene SCN1B. Nat Genet 1998; 19:366-70.
21. Singh NA, Charlier C, Stauffer D et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 1998; 18:25-9.
22. Biervert C, Schroeder BC, Kubisch C et al. A potassium channel mutation in neonatal human epilepsy. Science 1998; 279:403-6.
23. Charlier C, Singh NA, Ryan Sg et al. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genet 1998; 18:53-5.
24. Steinlein OK, Mulley JC, Propping P et al. A missense mutation in the neuronal nicotinic acetyl-choline receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 1995; 11:201-3.
25. De Fusco M, Becchetti A, Patrignani A et al. The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet 2000; 26:275-6.
26. Steinlein OK Genes and mutations in idiopathic epilepsy. Am J Med Genet 2001; 106:139-45.
27. Jacobs MP, Fischbach GD, Davis MR et al. Future directions for epilepsy research. Neurology 2001; 57:1536-1542.
28. Dietschy JM, Turley SD. Control of cholesterol turnover in the mouse. J Biol Chem 2002; 277:3801-3804.
29. Watanabe H, Nagata E, Kosakai A et al. Disruption of the epilepsy KCNQ2 gene results in neural hyperexcitability. J Neurochem 2000; 75:28-33.
30. Noebels JL. Single locus mutations in mice expressing generalized spike-wave absence epilepsies. Ital J Neurol Sci 1995; 16:107-11.
31. Noebels JL, Sidman RL. Inherited epilepsy: spike-wave and focal motor seizures in the mutant mouse tottering. Science 1979; 204:1334-1336.
32. Cox GA, Lutz CM, Yang CL et al. Sodium/hydrogen exchanger gene defect in slow-wave epilepsy mutant mice. Cell 1997; 91:139-48.
33. Frankel WN, Taylor L, Beyer B et al. Electroconvulsive thresholds of inbred mouse strains. Genomics 2001; 74:306-12.
34. Peterson SL, Electroshock. In: Peterson SL, Albertson TE, eds. Neuropharmacology Methods in Epilepsy Research. Boca Raton: CRC Press, 1998:1-26.
35. Ferraro TN, Golden GT, Smith GG et al. Mouse strain variation in maximal electroshock seizure threshold Brain Res 2002; 936:82-86.
36. Kitano Y, Usui C, Takasuna K et al. Increasing-current electroshock seizure test: A new method for assessment of anti- and pro-convulsant activities of drugs in mice. J Pharmacol Toxicol Methods 1996; 35:25-9.
37. White HS, Wolf HH, Woodhead JH et al. The National Institutes of Health Anticonvulsant Drug Development Program: Screening for efficacy. Adv Neurol 1998; 76:29-39.
38. Loscher W. New visions in the pharmacology of anticonvulsion. Eur J Pharmacol 1998; 342:1-13.
39. White HS. Chemoconvulsants. In: Peterson SL, Albertson TE, eds. Neuropharmacology Methods in Epilepsy Research. Boca Raton: CRC Press, 1998:27-40.
40. Skradski SL, Clark AM, Jiang H et al. A novel gene causing a mendelian audiogenic mouse epilepsy. Neuron 2001; 31:537-44.
41. Zheng QY, Johnson KR, Erway LC. Assessment of hearing in 80 inbred strains of mice by ABR threshold analyses. Hear Res 1999; 130:94-107.
42. Gerlai R. Gene-targeting studies of mammalian behavior: Is it the mutation or the background genotype? Trends Neurosci 1996; 19:177-81.
43. Bucan M, Abel T. The mouse: Genetics meets behavior. Nat Rev Genet 2002; 2:114-23.
44. Frankel WN. Mouse strain backgrounds: More than black and white. Neuron 1998; 20:183.
45. Schauwecker PE, Steward O. Genetic determinants of susceptibility to excitotoxic cell death: Implications for gene targeting approaches. Proc Natl Acad Sci USA 1997; 94:4103-8.
46. Ben-Ari Y, Cossart R. Kainate, a double agent that generates seizures: Two decades of progress. Trends Neurosci 2000; 23:580-7.
47. Goelz MF, Mahler J, Harry J et al. Neuropathologic findings associated with seizures in FVB mice. Lab Anim Sci 1998; 48:34-37.
48. Cox GA, Mahaffey CL, Frankel WN. Identification of the mouse neuromuscular degeneration gene and mapping of a second site suppressor allele. Neuron 1998; 1327-37.
49. Ferraro TN, Golden GT, Smith GG et al. Mapping loci for penrylenetetrazol-induced seizure susceptibility in mice. J Neurosci 1999; 19:6733-9.
50. Kosobud AE, Cross SJ, Crabbe JC. Neural sensitivity to pentylenetetrazol convulsions in inbred and selectively bred mice. Brain Res 1992; 592:122-8.
51. Ferraro TN, Golden GT, Smith GG et al. Mapping murine loci for seizure response to kainic acid. Mamm Genome 1997; 8:200-8.